Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 3 5Phase NA 1Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 33NIH 3NETWORK 2UNKNOWN 1OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Non-squamous Non-small Cell Lung Cancer 1

Interventions

Exercise 16Standard of Care 10Control Groups 9Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 6Radiotherapy 6Endoscopic Mucosal Resection 6Drug Therapy 6Blood Specimen Collection 6Indocyanine Green 5anlotinib 4Metformin 4Magnetic Resonance Spectroscopy 4Laparoscopy 4Fluorouracil 4Cisplatin 4apatinib 3Vitamin D 3Ultrasonography 3Therapeutics 3Sentinel Lymph Node Biopsy 3Saline Solution 3Radiofrequency Ablation 3Quality of Life 3Proton Therapy 3Preoperative Exercise 3Methylene Blue 3Mammography 3Magnetic Resonance Imaging 3Hematologic Tests 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × OTHER_GOV × Docetaxel × Clear all
NCT03566576 2018-06-25

Phase I Study of the Combination of Anlotinib With Pemetrexed or Docetaxel

Fujian Cancer Hospital

Phase NA Unknown
18 enrolled
Thoracic

Non-squamous Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡